Search research articles
Contact Us
Filters
Showing results (1-10 of 162) with videos related to
Page
of 17
Sort By:
The Lancet. Oncology
|
June 29, 2026
SUBITO: validating biology, not intensity
Alberto Zambelli
Frontiers in Oncology
|
February 10, 2023
Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
Alberto Zambelli, Maurizio D'Incalci
Expert Opinion on Investigational Drugs
|
November 24, 2015
Trabectedin for the treatment of breast cancer
Maurizio D'Incalci, Alberto Zambelli
ESMO Open
|
July 15, 2020
Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
Alberto Zambelli, Carlo Alberto Tondini
Cancer Treatment Reviews
|
February 28, 2026
Phase III placebo-controlled oncology trials in the last decade: evolution, methodological foundations, and clinical impact
Fausto Petrelli, Lorenzo Dottorini, Alberto Zambelli
Advances in Experimental Medicine and Biology
|
October 30, 2020
HGF/c-Met Signalling in the Tumor Microenvironment
Alberto Zambelli, Giuseppe Biamonti, Angela Amato
Journal of Comparative Effectiveness Research
|
February 15, 2020
Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY: a GRADE analysis
Alberto Zambelli, Giovanni Pappagallo, Paolo Marchetti
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 14, 2009
Seizure associated with palonosetron
Alberto Zambelli, Paola Sagrada, Lorenzo Pavesi
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2009
From cancer patients to cancer survivors: the issue of Cardioncology--a biological perspective
Alberto Zambelli, Matteo Della Porta, Vittorio Rosti
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 20, 2026
Budget impact analysis of Oncotype DX<sup>®</sup> multigenic prognostic test in patients with early breast cancer in Italy
Oriana Ciani, Carlo Federici, Daniele Generali, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 162) with videos related to
Sort By:
Page
of 17
The Lancet. Oncology
|
June 29, 2026
SUBITO: validating biology, not intensity
Alberto Zambelli
Frontiers in Oncology
|
February 10, 2023
Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives
Alberto Zambelli, Maurizio D'Incalci
Expert Opinion on Investigational Drugs
|
November 24, 2015
Trabectedin for the treatment of breast cancer
Maurizio D'Incalci, Alberto Zambelli
ESMO Open
|
July 15, 2020
Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
Alberto Zambelli, Carlo Alberto Tondini
Cancer Treatment Reviews
|
February 28, 2026
Phase III placebo-controlled oncology trials in the last decade: evolution, methodological foundations, and clinical impact
Fausto Petrelli, Lorenzo Dottorini, Alberto Zambelli
Advances in Experimental Medicine and Biology
|
October 30, 2020
HGF/c-Met Signalling in the Tumor Microenvironment
Alberto Zambelli, Giuseppe Biamonti, Angela Amato
Journal of Comparative Effectiveness Research
|
February 15, 2020
Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY: a GRADE analysis
Alberto Zambelli, Giovanni Pappagallo, Paolo Marchetti
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 14, 2009
Seizure associated with palonosetron
Alberto Zambelli, Paola Sagrada, Lorenzo Pavesi
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2009
From cancer patients to cancer survivors: the issue of Cardioncology--a biological perspective
Alberto Zambelli, Matteo Della Porta, Vittorio Rosti
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 20, 2026
Budget impact analysis of Oncotype DX<sup>®</sup> multigenic prognostic test in patients with early breast cancer in Italy
Oriana Ciani, Carlo Federici, Daniele Generali, et al.
Page
of 17